T&G // TERMINAL All desk notes →
NY Pre-Market Brief

Futures rip as VIX craters and oil eases on Iran ceasefire chatter; tech leads

Tuesday, July 21, 2026 · the tape framed before the US open

Risk snaps back hard pre-open: VIX down near 6% and tech-led futures erasing Monday's oil-driven slide ahead of a loaded earnings tape.

SPY is bid to roughly the mid-$740s (last ~$746, +0.5-1.3%) and QQQ is outperforming near $700-705 (+1.3-1.4%), clawing back Monday's session where the S&P slipped 0.19% to 7,443.28 on rising crude. VIX at 17.58, down 5.7%, is unwinding fast even as the CNN Fear & Greed gauge still sits at 37.6 in "fear" — sentiment lagging the tape. Polymarket odds imply a 95% chance of a higher open, with easing oil after reports mediators are pushing a 10-day Iran ceasefire following 10 straight nights of US strikes.

No live GEX this run, so treat levels as indicative: SPY flip sits near 742 (Monday's close/support), with a call-wall zone into 750 round-number resistance capping upside on a VIX-crush day. QQQ support is Monday's low near 695, with semis (Taiwan export strength, NVDA's stake in Nebius) doing the heavy lifting. Fed funds futures price an 83.4% chance of a hold this cycle, keeping macro a backdrop, not the driver — the driver today is oil and earnings, with Danaher, 3M, Halliburton, GM, Schwab, MSCI and Northrop before the bell setting the cyclical/industrial tone ahead of Alphabet, IBM and Intel later this week.

The risk: this is a vol-crush unwind on ceasefire hope, not confirmed de-escalation — a stalled talks headline or the threatened Houthi blockade on Saudi flow snaps crude back up, VIX re-bids, and the 742 flip fails fast.

This note is written from live dealer positioning.

The same gamma data behind it — the flip, the call and put walls, and where price sits between them — is on the terminal for any ticker, updated through the session. Every setup we publish carries its entry, stop and target before the trade, and gets graded in the open afterwards.

Score any ticker free →
HomeScore a tickerPlans Disclaimer Structure, not financial advice.